Opportunity Information: Apply for RFA GH09 002
Apply for RFA GH09 002
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Addressing Emerging Infectious Diseases and Related Public Health Threats in the Peoples Republic of China (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 5, 2009 and posted on Mar 5, 2009.
- Applicants must submit their applications by May 4, 2009 Letter of Intent Receipt Date April 6, 2009 Application Submission Receipt Date May 4, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $200,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 20 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Institutions You may submit an application if your organization has any of the following characteristics Foreign Institutions Application for this program is limited to the Ministry of Health (MOH) of the People s Republic of China and institutions affiliated with the MOH. MOH affiliated institutions are the Chinese Academy of Medical Sciences (Peking Union Medical College), the Chinese Center for Disease Control and Prevention, the Chinese Academy of Science, the National Center of Health Inspection and Supervision, Beijing Hospital, China Japan Friendship Hospital, the China Medical Association, Health Daily, the Peoples Medical Publishing House, the China Prevention Medicine Association, the Training Center for Health Officials, the Development Center for Medical and Health Technology, the Health Economics Center, the Hospital Management Center, the Personnel Exchange Center, the Logistics Center for the Ministry of Health, and any other institution in China that has a documented direct affiliation with the Chinese Ministry of Health. This limited eligibility is based on the key objectives of the program to develop and implement infectious disease research projects and allow the organization to carry out multiple and ongoing public health research activities in China.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Addressing Emerging Infectious Diseases and Related Public Health Threats in the People's Republic of China (U01)" (Funding Opportunity Number RFA GH09-002), is a CDC cooperative agreement designed to build and strengthen infectious disease and public health threat detection and evaluation capacity within China. The central idea is to support work that helps identify, measure, and reduce the impact of both existing infectious diseases and newly emerging or re-emerging threats that could have regional or global consequences. Because China experiences a relatively higher incidence of certain serious infectious diseases and has large, diverse populations, the CDC frames the country as an important setting for learning more about disease epidemiology, understanding how preventable these diseases are, and spotting outbreaks early, including threats with pandemic potential such as influenza.
The program emphasizes practical, applied public health research and surveillance-strengthening activities that can be sustained over time. Key activities highlighted in the announcement include improving the ability to detect and evaluate infectious diseases and related threats, estimating the burden of specific infectious diseases (for example, measuring incidence, severity, complications, and mortality), and generating evidence that informs prevention policy. A major focus is on vaccines: the program aims to support evaluations of vaccine acceptability (whether communities and providers are willing to use them), vaccine efficacy and effectiveness (how well vaccines work in controlled conditions and in real-world settings), and broader immunization-related strategies. In addition to vaccines, the opportunity explicitly supports evaluation of other interventions that could reduce disease burden, which can include public health measures, clinical management approaches, infection control strategies, or other prevention programs aligned with infectious disease control goals.
The funding instrument is a cooperative agreement (U01), meaning CDC involvement is expected to be more collaborative than in a typical grant. In practice, that usually implies substantial federal scientific or programmatic engagement during project implementation, such as coordination on study design, surveillance methods, data standards, evaluation plans, or technical assistance tied to strengthening public health systems. The opportunity sits within the health activity category and is linked to the Healthy People 2010 focus area of immunization and infectious diseases, reinforcing its orientation toward population-level prevention, immunization impact, and infectious disease control outcomes.
Eligibility is narrowly limited to the Chinese Ministry of Health (MOH) of the People's Republic of China and institutions directly affiliated with the MOH. The announcement lists examples of MOH-affiliated entities, including the Chinese Academy of Medical Sciences (Peking Union Medical College), the Chinese Center for Disease Control and Prevention, the Chinese Academy of Science, and multiple other MOH-linked hospitals, associations, publishing and training entities, and administrative centers, as well as any other China-based institution with documented direct affiliation to the MOH. This restricted eligibility is justified in the notice as necessary to meet the program's objectives: to develop and implement infectious disease research projects and to enable sustained, ongoing public health research and related activities within China through MOH-connected structures.
From an administrative standpoint, the opportunity was posted March 5, 2009, with a letter of intent due April 6, 2009, and applications due May 4, 2009; it was archived June 3, 2009. The CDC anticipated making up to 20 awards, with an estimated total funding amount of $200,000 and an award ceiling of $200,000 (with an award floor listed as $0). No cost sharing or matching requirement was specified. The CFDA number associated with the program is 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance), which aligns with the technical-assistance and public health investigation orientation described in the narrative. For applicants needing help accessing the full announcement, the contact listed is the CDC Procurement and Grants Office Technical Information Management Section (phone 770-488-2700).
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Addressing Emerging Infectious Diseases and Related Public Health Threats in the People's Republic of China (U01)."
What is the funding opportunity number?
The Funding Opportunity Number is RFA GH09-002.
Which federal agency is offering this opportunity?
This is a CDC (Centers for Disease Control and Prevention) cooperative agreement opportunity.
What type of funding instrument is used?
The funding instrument is a cooperative agreement (U01).
What does a U01 cooperative agreement mean for how the project is run?
A U01 cooperative agreement indicates CDC involvement is expected to be collaborative and substantial during project implementation, such as coordination on study design, surveillance methods, data standards, evaluation plans, and technical assistance tied to strengthening public health systems.
What is the overall purpose of this program?
The purpose is to build and strengthen infectious disease and related public health threat detection and evaluation capacity within China, supporting work that helps identify, measure, and reduce the impact of existing infectious diseases and newly emerging or re-emerging threats that could have regional or global consequences.
Why is the program focused on China?
The announcement frames China as an important setting due to a relatively higher incidence of certain serious infectious diseases and large, diverse populations. It emphasizes opportunities to learn more about disease epidemiology, understand how preventable these diseases are, and spot outbreaks early, including threats with pandemic potential such as influenza.
What kinds of activities does the announcement highlight?
Highlighted activities include strengthening the ability to detect and evaluate infectious diseases and related threats, estimating the burden of specific infectious diseases, and generating evidence that informs prevention policy.
What does "estimating disease burden" mean in this opportunity?
The announcement describes disease burden estimation in terms of measuring factors such as incidence, severity, complications, and mortality for specific infectious diseases.
Is the program focused on research, surveillance, or both?
It emphasizes practical, applied public health research and surveillance-strengthening activities, with an emphasis on approaches that can be sustained over time.
How does the opportunity address emerging or re-emerging threats?
It supports efforts that improve early detection and evaluation of outbreaks and threats, including newly emerging or re-emerging infectious diseases that may have regional or global impacts.
Does the announcement mention pandemic-related threats?
Yes. It explicitly notes the importance of spotting outbreaks early, including threats with pandemic potential such as influenza.
What is the role of vaccines in this opportunity?
Vaccines are a major focus. The program aims to support evaluations of vaccine acceptability, vaccine efficacy and effectiveness, and broader immunization-related strategies.
What is meant by vaccine acceptability in this context?
Vaccine acceptability is described as whether communities and providers are willing to use vaccines.
What is meant by vaccine efficacy and vaccine effectiveness?
The announcement distinguishes between efficacy (how well vaccines work under controlled conditions) and effectiveness (how well vaccines work in real-world settings).
Are non-vaccine interventions eligible under this opportunity?
Yes. The opportunity explicitly supports evaluation of other interventions that could reduce disease burden, including public health measures, clinical management approaches, infection control strategies, or other prevention programs aligned with infectious disease control goals.
What health category is this program associated with?
The opportunity sits within the health activity category.
Is this opportunity tied to a specific Healthy People focus area?
Yes. It is linked to the Healthy People 2010 focus area of immunization and infectious diseases.
Who is eligible to apply?
Eligibility is narrowly limited to the Chinese Ministry of Health (MOH) of the People's Republic of China and institutions directly affiliated with the MOH.
Are China-based institutions outside the MOH eligible?
Only if they have documented direct affiliation to the MOH, as described in the announcement.
What examples of MOH-affiliated entities are provided?
Examples listed include the Chinese Academy of Medical Sciences (Peking Union Medical College), the Chinese Center for Disease Control and Prevention, the Chinese Academy of Science, and multiple other MOH-linked hospitals, associations, publishing and training entities, and administrative centers.
Why is eligibility restricted to MOH and MOH-affiliated institutions?
The notice states the restricted eligibility is necessary to meet the program's objectives: to develop and implement infectious disease research projects and enable sustained, ongoing public health research and related activities within China through MOH-connected structures.
When was the opportunity posted?
The opportunity was posted on March 5, 2009.
Was a letter of intent required, and when was it due?
A letter of intent was due on April 6, 2009.
When were applications due?
Applications were due on May 4, 2009.
Is this funding opportunity still open?
No. The opportunity was archived on June 3, 2009.
How many awards did CDC anticipate making?
The CDC anticipated making up to 20 awards.
What was the estimated total funding amount?
The estimated total funding amount was $200,000.
What was the maximum award amount (ceiling)?
The award ceiling was listed as $200,000.
What was the minimum award amount (floor)?
The award floor was listed as $0.
Was cost sharing or matching required?
No cost sharing or matching requirement was specified in the information provided.
What is the CFDA number for this program?
The CFDA number is 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance).
How does the CFDA description relate to the program?
The CFDA number provided aligns with the technical-assistance and public health investigation orientation described in the opportunity narrative.
Who can be contacted for help accessing the full announcement?
The listed contact is the CDC Procurement and Grants Office Technical Information Management Section at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Recovery Act Limited Competition Core Facility Renovation, Repair, and Improvement (G20)
Previous opportunity: Riparian Brush Rabbit Captive Propagation
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GH09 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GH09 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Phased Innovation Award Program for AIDS Vaccine Research (R21/R33) Apply for PA 09 119 Funding Number: PA 09 119 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Public Health Traineeship Apply for HRSA 09 201 Funding Number: HRSA 09 201 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Novel Interventions for Neurodevelopmental Disorders (R34) Apply for RFA MH 09 160 Funding Number: RFA MH 09 160 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Novel Interventions for Neurodevelopmental Disorders (R21/R33) Apply for RFA MH 09 161 Funding Number: RFA MH 09 161 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| International Collaborations in Infectious Disease Research (ICIDR) (U01) Apply for RFA AI 09 010 Funding Number: RFA AI 09 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Addressing Asthma from a Public Health Perspective Apply for CDC RFA EH09 901 Funding Number: CDC RFA EH09 901 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $950,000 |
| 2009 FPH Region 2 (Virgin Islands) Apply for PA FPH 09 002 Funding Number: PA FPH 09 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $853,000 |
| Prematurity and Respiratory Outcomes Program (PROP) (U01) Apply for RFA HL 10 007 Funding Number: RFA HL 10 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Sudden Unexpected Infant Death Case Registry A Pilot Study Apply for CDC RFA DP09 904 Funding Number: CDC RFA DP09 904 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $130,000 |
| SPRANS Cooperative Agreement Programs Health Insurance Financing for Children with Special Health Apply for HRSA 09 137 Funding Number: HRSA 09 137 Agency: Health Resources and Services Administration Category: Health Funding Amount: $550,000 |
| Capacity Building Assistance (CBA) to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Services for High Risk and/or Racial/Ethnic Minority Populations Apply for CDC RFA PS09 906 Funding Number: CDC RFA PS09 906 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,462,500 |
| Department of Defense HIV/AIDS Prevention, Care and Treatment Program Apply for DHAPPBAA09 002 Funding Number: DHAPPBAA09 002 Agency: Naval Supply Systems Command Category: Health Funding Amount: Case Dependent |
| Alcohol Research Resource Awards (R24) Apply for PAR 09 128 Funding Number: PAR 09 128 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Probe Production Centers Network (MLPCN) (R03) Apply for PAR 09 129 Funding Number: PAR 09 129 Agency: National Institutes of Health Category: Health Funding Amount: $25,000 |
| Exploratory Investigations in Food Allergy (R21) Apply for RFA AI 09 011 Funding Number: RFA AI 09 011 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Dental Reimbursement Program Apply for HRSA 09 133 Funding Number: HRSA 09 133 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Telehealth Resource Center Grant Program Apply for HRSA 09 195 Funding Number: HRSA 09 195 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Statewide Consumer Network Grant Apply for SM 09 014 Funding Number: SM 09 014 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Mental Health Dissertation Research Grant to Increase Diversity (R36) Apply for PAR 09 132 Funding Number: PAR 09 132 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Support for Strengthening and Expanding Comprehensive HIV and AIDS Prevention Programs in the Republic of South Africa under PEPFAR Apply for CDC RFA PS09 939 Funding Number: CDC RFA PS09 939 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,810,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH09 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.